MIAMI, FL – Following a direct hit by Hurricane Irma this past weekend, VIVEX Biologics Inc. facilities and staff are unharmed. Despite significant damage to Miami and other areas of Southwest Florida, we are thankful to report that our employees and their families are safe.

VIVEX facilities did not experience power loss and all operations resumed on Wednesday, September 13. We will continue to support client and customer needs as we return to normal operations.

Thank you for your concern for the safety of our employees, their families, and the people of Miami. We are grateful for your support.

VIVEX is ready and prepared to rebound from Hurricane Irma stronger than before to support the advancement of allograft transplantation. We remain committed to providing care and compassion to donor families while inspiring communities to share life by donating.

We are closely monitoring Hurricane Irma and anticipate that the office will be closed on Friday, 9/8.  Please ensure that all orders that need to be shipped are submitted by end of day 5pm EST on Thursday, 9/7 for any allograft needs. 

After hours service will not be available once we begin to encounter tropical storm force winds.  For all urgent requests, please contact customer service at 1-888-684-7783 to receive additional assistance. Thank you.

FORT LAUDERDALE/DAVIE, Fla. – The Greater Miami Chamber of Commerce honored H. Thomas Temple, M.D., as a “Health Care Hero” at its 20^th annual Health Care Heroes® Award ceremony, which was held May 9, 2017 at Jungle Island in Miami. Dr. Temple, who is senior vice president of translational research and economic development for Nova Southeastern University (NSU), was the recipient of the Bio-Medical Award for his lifetime of work in this field.

“Dr. Temple is multidimensional—an inventor, a surgeon, a university administrator and a family man,” said NSU President Dr. George Hanbury, who nominated Dr. Temple for the award. “Through all of these roles, his goal is simple—to make a lasting impact on humanity.”

According to the Chamber, the Health Care Heroes® Awards program recognizes individuals, institutions, professionals, students, volunteers and programs, who through their individual or collective actions have made an extraordinary impact in the South Florida health care community.

Health Care Heroes’ acts of heroism represent a display of dedication to excellence in their area of expertise beyond the scope of their jobs. Through their commitment to their profession and community, they serve as an inspiration to others in an effort to improve the quality of health care and discover new ways to assist those in need.

A world-class orthopedic surgeon whose career spans three decades, Dr. Temple specializes in treating both children and adults with bone and soft tissue cancers. His work in orthopedic oncology has focused on sparing limbs for patients with bone tumors and finding alternative ways to treat them without using toxic chemotherapy.

In his work with Nova Southeastern University and VIVEX Biologics, Inc., Dr. Temple has played a key role in multiple biomedical inventions that have made a difference in the lives of people throughout the world, helping them regain the use of their limbs and joints. His key products include the MIAMI (marrow-isolated adult multi-lineage inducible) cell, a type of stem cell derived from adult bone marrow; VIA Graft, used to regenerate bone; BioCartilage, marketed internationally for cartilage repair; VIA Disc, an intervertebral disc cell matrix that restores diseased discs; and a host of other regenerative orthopaedic products. He currently holds 12 patents, all of which have been developed into commercial products to treat patients.

Tracy S. Anderson, CEO of VIVEX Biologics, Inc., regarded Dr. Temple’s award fondly. “We at VIVEX are so excited that Dr. Temple has been recognized in this way.  He is a mainstay in the Miami community and has been instrumental in changing so many people’s lives.  This is a very well deserved honor.”

As NSU’s senior vice president of translational research and economic development, he is responsible for building the connections, resources and entrepreneurial energy for the commercialization of the university’s research activities to foster research that makes a direct impact on people and the environment. He also serves as executive associate dean for research for NSU’s College of Allopathic Medicine (M.D. College). He has already achieved much success, most notably through the creation of the NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from NSU’s M.D. College and Sweden’s world-renowned Karolinska Institutet (KI), which is focused on conducting pioneering cell-based biomedical research.

His current research efforts are centered around creating and expanding tissue and cell libraries that can be used to develop targeted strategies to treat patients with malignant tumors of the skeletal system.

About VIVEX Biologics, Inc.

VIVEX Biologics, Inc. is a regenerative biologics company, dedicated to creating novel products for patient care. Founded in 2014, VIVEX and UMTB (founded 1970) strive for methods to convert translational research into treatments for patients.

VIVEX’s primary goal is translating innovation into treatments for patients, further expanding surgical options, and fulfilling surgeon needs. At the present time, research and development is focused on making strides across biologics and regenerative medicine, with major areas of investigation including: cartilage, soft tissue, bone, and skin. Focuses include amniotic fluid therapy, viable allogenic bone allografts, and amniotic tissue matrices.

VIVEX works closely with community partners that are committed to providing care and compassion to donor families, while simultaneously inspiring communities to donate. Partnering with others ensures that families are offered the appropriate options and support for donation, including Life Alliance, the Lions Eye Bank, Brain Bank, and Medical Examiners.

About Nova Southeastern University (NSU) 

Located in beautiful Fort Lauderdale, Florida, Nova Southeastern University (NSU) is a dynamic research institution dedicated to providing high-quality educational programs at the undergraduate, graduate, and first-professional degree levels. A private, not-for-profit institution, NSU has campuses in Fort Lauderdale, Fort Myers, Jacksonville, Miami, Miramar, Orlando, Palm Beach, and Tampa, Florida, as well as San Juan, Puerto Rico, while maintaining a presence online globally. For more than 50 years, NSU has been awarding degrees in a wide range of fields, while fostering groundbreaking research and an impactful commitment to community. Classified as a research university with “high research activity” by the Carnegie Foundation for the Advancement of Teaching, NSU is 1 of only 50 universities nationwide to also be awarded Carnegie’s Community Engagement Classification, and is also the largest private, not-for-profit institution in the United States that meets the U.S. Department of Education’s criteria as a Hispanic-serving Institution. Please visit www.nova.edu for more information about NSU and realizingpotential.nova.edu for more information on the largest fundraising campaign in NSU history.

May 10, 2017

Contact Information:
Jeremy Katzman, M.B.A., APR
954-262-5408 (office)
954-661-7000 (cell)
j.katzman@nova.edu

Heritage Bank of Commerce Provides $9 Million Facility to VIVEX Biologics, Inc.

Heritage Bank of Commerce, the operating bank of Heritage Commerce Corp (NASDAQ:HTBK), today announced that they have provided VIVEX Biologics, Inc., based in Atlanta, Georgia, a $9 million line of credit and other financial services to support VIVEX’s growth in the biomedical industry.

“VIVEX’s business is accelerating on every front, and we needed a financial partner able to support rapid, multi-faceted growth,” said Tracy Anderson, President and CEO of VIVEX. “We are constantly striving for creative treatment options and solutions to progress clinical, surgical and therapeutic patient care. We will use the additional funding for new product development, to expand operations, and for working capital and general corporate purposes. Heritage Bank of Commerce is a financial institution that understands the needs of our company.”

“We are very pleased to be working with VIVEX,” said Mike Hansen, Senior Vice President, Corporate Finance at Heritage Bank of Commerce. “We feel our line of credit will assist with their capital needs as they continue to grow and we look forward to a successful partnership.”

“Our goal is to partner with VIVEX and provide services that best meet their growing business needs,” said Jeffrey Javier, Senior Vice President, Corporate Finance at Heritage Bank of Commerce. “We look forward to watching them grow and drive the future of the biomedical industry.”

About VIVEX Biologics, Inc.

VIVEX Biologics, Inc. is a regenerative biologics company, dedicated to creating novel products for patient care. Founded in 2014, VIVEX and UMTB (founded 1970) strive for methods to convert translational research into treatments for patients.

VIVEX’s primary goal is translating innovation into treatments for patients, further expanding surgical options, and fulfilling surgeon needs. At the present time, research and development is focused on making strides across biologics and regenerative medicine, with major areas of investigation including: cartilage, soft tissue, bone, and skin. Focuses include amniotic fluid therapy, viable allogenic bone allografts, and amniotic tissue matrices.

VIVEX works closely with community partners that are committed to providing care and compassion to donor families, while simultaneously inspiring communities to donate. Partnering with others ensures that families are offered the appropriate options and support for donation, including Life Alliance, the Lions Eye Bank, Brain Bank, and Medical Examiners.

About Heritage Bank Of Commerce

Heritage Commerce Corp, a bank holding company established in February 1998, is the parent company of Heritage Bank of Commerce, established in 1994 and headquartered in San Jose with full service branches in Danville, Fremont, Gilroy, Hollister, Los Altos, Los Gatos, Morgan Hill, Pleasanton, Sunnyvale, and Walnut Creek. Heritage Bank of Commerce is an SBA Preferred Lender. Bay View Funding, a subsidiary of Heritage Bank of Commerce, is based in Santa Clara and provides business essential working capital factoring financing to various industries throughout the United States. For more information, please visit www.heritagecommercecorp.com.

Contact: Diana Olveira / VP Marketing

408.534.4930

SAN JOSE, Calif., April 05, 2017 (GLOBE NEWSWIRE)

VIVEX Biologics, Inc. (VIVEX) is a biomaterials developer focused on creating treatment options and creative solutions to advance clinical, surgical and therapeutic patient care. It has made significant progress in a short time, bringing together the brightest minds in the scientific community and from the orthopaedic and material science industries. With its focus on continued innovation in next-generation biomaterials, VIVEX is creating a new standard in patient care and delivering groundbreaking health products to meet the needs of a diverse, rapidly expanding market.

“VIVEX is very excited to receive this unique Level II HCPCS Q-Code for Cygnus, one of our premiere amniotic tissue allografts,” commented Michele Pablos, Vice President of Sales and Marketing. “Our goal is to make our products more affordable based on the operating needs of all payers, and this is a huge step in making that goal a reality.”

“Cygnus, an amniotic tissue matrix with innate regenerative capability to support healing, is a product that is available in multiple sizes for multiple uses. Cygnus’ amnion patch is an immune-privileged tissue with proven clinical success in regenerative healing, and we look forward to providing more payers with the opportunity to use it.”

This Q-code set is available for use by an array of payers, and is maintained by the Centers for Medicare and Medicaid Services (CMS).

About VIVEX Biologics, Inc., Powered by UMTB:

VIVEX Biologics, Inc. is a regenerative biologics company, dedicated to creating new standards in patient care. Since 2014, VIVEX and UMTB (founded 1970) have strived for methods to translate creative collaborations into treatments for real problems.

In collaboration with multiple partners, VIVEX is on the cutting edge of scientific development. Translating innovation into treatments for real problems further expands surgical options. All research and development is focused on making strides in the field of musculoskeletal regenerative medicine, with major areas of investigation including: cartilage, bone, and skin. Innovative vision provides a platform that assists in the regeneration of all these tissue types in a personalized but scalable transplantation model.

VIVEX is constantly working closely with services that support the advancement of allograft transplantation, specifically services that are committed to providing care and compassion to donor families while inspiring communities to share life by donating. Partnering with others ensures that families are offered the appropriate options and support for donation, including Life Alliance, the Lions Eye Bank, Brain Bank, and Medical Examiners.

ATLANTA Dec. 20, 2016 /PRNewswire

Join VIVEX at the World Stem Cell Summit, booth 318, for the original, translation-focused global meeting of stakeholders. No other event brings the entire ecosystem together in a single place. Meet the stem cell field’s top innovators, leading scientists, clinicians, investors, advocates, customers, legal experts, elected officials, philanthropists, regulators, and patients.

Top reasons to attend

• Make connections with the world’s top thought leaders, decision makers, investors, and influencers
• Stay on the cutting edge of hot topics and future trends
• Be a part of the future of regenerative medicine

Professor Norio Nakatsuji, Founding Director of Kyoto University’s iCeMS, says “The World Stem Cell Summit has become a must-attend event for top researchers.” The focus on translation and commercialization attracts all stakeholders in the regenerative medicine universe. It gives high-touch visibility to innovative work, products, and services while encouraging collaborations and relationships across all disciplines.

• 1,200+ Attendees from 40+ countries
• 1,000+ Online streaming audience
• 225+ Renowned international speakers
• 200+ Sponsors, exhibitors, endorsing organizations, and media partners
• 90+ Hours of programming
• 70+ Exhibitors
• 30+ Expert luncheon roundtable discussions

The VIVEX team will be in West Palm Beach, Florida at booth 318 December 6-9th. Join us for this world-class event.

About VIVEX

VIVEX is dedicated to exploring new ways to help others. Under the guidance of experienced and successful business professionals, we take products from ideation all the way to clinical implementation. We are constantly striving for creative treatment options and solutions to progress clinical, surgical, and therapeutic patient care by expanding industry knowledge and capability.

Bonnie Anderson Black, the mother of VIVEX President and Chief Executive Officer Tracy Anderson, has suffered from arthritis in her hands for decades. The arthritis was so painful, she could not hold onto things and it kept her from doing things she loved, like gardening. Not wanting to see his mother in pain, Mr. Anderson reached out to Doctor Michael Shuler, a top hand surgeon at the Athens Orthopedic Clinic. Together, they injected VIVEX Allogen-LI into the pads of Bonnie’s thumbs and two trigger fingers. Just two days later, Bonnie’s was pain gone. She recovered full use of her hands and could make a fist again, leaving her with a new lease on life. “It’s just like I have new hands. I’m elated! I’m very satisfied,” she proclaimed two days after surgery. Thanks to the amniotic fluid therapy of Allogen-LI, Bonnie can return to her life before arthritis and get back to gardening.

Allogen-LI, a multipurpose amniotic fluid therapy that provides a non-surgical treatment option for inflammation, injury, or chronic pain. The safe, 100% natural fluid contains no harmful additives and has treated Tendinitis, Tendinosis, Plantar Fasciitis, Fasciosis, Patellofemoral pain syndrome, Epicondylitis, joint inflammation, Bursitis, muscle tears, and injuries.

About VIVEX
VIVEX is dedicated to exploring new ways to help others. Under the guidance of experienced and successful business professionals, we take products from ideation all the way to clinical implementation. We are constantly striving for creative treatment options and solutions to progress clinical, surgical, and therapeutic patient care by expanding industry knowledge and capability.

Come by and say hello and learn about some exciting new treatment options for your patients! Share in the latest information, innovative technologies, and best practices with some of the most renowned spine care professionals and scientists from around the world.

For more information on VIVEX’s creative treatment options and solutions, contact Michele at mpablos@vivex.com or Holly at holly@vivex.com.

About VIVEX
VIVEX is dedicated to exploring new ways to help others. Under the guidance of experienced and successful business professionals, we take products from ideation all of the way to clinical implementation. We are constantly seeking to provide creative treatment options and solutions to progress clinical, surgical, and therapeutic patient care by expanding industry knowledge and capability.